Wells Fargo & Company PREVAIL THERAPEUTICS INC Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
N/A
-32,479 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
N/A
22,979 Added 241.88%
32,479 $749,000
Q3 2020

Nov 05, 2020
SELL
N/A
-1,628 Reduced 14.63%
9,500 $97,000
Q2 2020

Aug 13, 2020
SELL
N/A
-10,240 Reduced 47.92%
11,128 $166,000
Q1 2020

May 14, 2020
BUY
N/A
21,368 New
21,368 $260,000
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email